RFP ATTACHMENT 2- Pegfilgrastim Q and A Responses.pdf
PDF 152 KB Posted
- Attached to
- Pegfilgrastim with VMI Federal contract opportunity
- Solicitation number
- RFP_75A50324R00004
About this file
This document is a Question and Answer sheet related to a Request for Proposal (RFP) for the acquisition of Pegfilgrastim 6MG/.06ML (INJ, SOLN, SYR, or Autoinjector) and Vendor Managed Inventory (VMI) services by the Center for the Strategic National Stockpile (SNS) of the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR).
The key details include: the Government's intent to unilaterally exercise option years, an extension of the proposal submission deadline to October 2, 2024, clarification that the RFP evaluation criteria do not assign additional value to a domestic supply chain or autoinjector presentations, and confirmation that offerors can submit separate prices for different Pegfilgrastim forms. The RFP requires compliance with the Trade Agreements Act and readiness for mass casualty events. No other products or services beyond Pegfilgrastim and VMI are specified in this Q&A document.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| RFP 75A50324R00004 Amendment 2 10.02.2024.pdf | ||
| RFP ATTACHMENT 2- Pegfilgrastim Q and A Template (Government Comments) 10.02.2024.pdf | ||
| RFP 75A50324R00004 Amendment 1 Peg.pdf | ||
| RFP 75A50324R00004.pdf | ||
| RFP 75A50324R00004_Attachement 1 - SBCX Industry Subcontracting Guide.pdf | ||
| Copy of RFP Attachment 4 - Pegfilgrastim Past Performance Questionnaire Template.xlsx | XLSX spreadsheet | |
| RFP Attachement 5 - Representations and CertificationsCommercial Products and Commercial Services. MAY.pdf | ||
| RFP ATTACHMENT 2- Pegfilgrastim Q and A Template.docx | DOCX document | |
| RFP Attachment 3 - Pegfilgrastim Pricing Template (003).docx | DOCX document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
ATTACHMENT 2
SOLICITATION Q & A Sheet
REQUIREMENT TITLE: Pegfilgrastim 6MG/.06ML (INJ, SOLN, SYR, or Autoinjector) and Vendor Managed Inventory (VMI) services
SOLICITATION NO. 75A50324R00004
Note: Use this sheet to submit Questions. The government will consolidate all questions received and will provide responses to all vendors in blue.
1. CONTRACTOR’S QUESTION:
RFP Section
Question Document
Name Section Paragraph Page Solicitation
Language
RFP
B.1 Will option years outlined in the solicitation be exercised unilaterally by the government?
GOVERNMENT’S RESPONSE: Yes, it is the Government intent to exercise the option years unilaterally.
2. CONTRACTOR’S QUESTION:
Question Document
Name Section Paragraph Page Solicitation Language
Would it be possible to receive an extension on the proposal submission deadline?
GOVERNMENT’S RESPONSE: Yes, the proposal submission deadline has been extended to 4:00 PM ET on 02 October 2024.
3. CONTRACTOR’S QUESTION:
Question Document Name Section Paragraph Page Solicitation Language
Is there a way to check the portfolio covered by SNS? For example, we are curious if SNS covers antibiotics or other injectables.
GOVERNMENT’S RESPONSE: This RFP is for the acquisition of pegfilgrastim. Any other requirements for SNS would be posted or announced on sam.gov or via other mechanisms consistent with federal regulations.
4. CONTRACTOR’S QUESTION:
Section M As awards are being made based on best value, does the evaluation criterion assign additional value to a domestic (i.e., U.S.
based) supply chain for the manufacture, fill, and finish of these products?
Should the locations of the supply chain be detailed by stage?
GOVERNMENT’S RESPONSE: The Government will evaluate each Offeror’s technical proposal on its ability to demonstrate their capability to provide FDA-approved Pegfilgrastim for hematopoietic subsyndrome treatment, with compliance to the Trade Agreements Act (TAA) and readiness for mass casualty events. The evaluation criteria do not assign additional value to a domestic (i.e., U.S. based) supply chain for the manufacture, fill, and finish of these products.
The Offeror’s response should be detailed enough to allow the Government to properly evaluate the proposal to ensure it meets the requirement of the SOW (Section C of the RFP).
Section M As awards are being made based on best value, does the evaluation criterion assign additional value to an autoinjector (AI) forms based on ease of use by the patient and/or end user?
GOVERNMENT’S RESPONSE: The Government will evaluate the Offeror’s ability to provide FDA-approved Pegfilgrastim for hematopoietic subsyndrome treatment. The evaluation criteria do not assign additional value to an autoinjector (AI) presentation based on ease of use by the patient and/or end user.
5. CONTRACTOR’S QUESTION:
Question Document Name Section Paragraph Page Solicitation Language
RFP #
75A50324R00004
Section M Can two separate prices be offered if we offer two different forms of pegfilgrastim? (i.e., two separate prices, one per different form) for the
RFP?
GOVERNMENT’S RESPONSE: All offers submitted in response to the solicitation will be reviewed.
File details come from the government source that posted it. Updated .